Iterum Therapeutics plc announced the appointment of Sailaja Puttagunta, M.D., to the newly created position of Chief Medical Officer, where she will oversee global clinical development and regulatory initiatives for Iterum. Dr. Puttagunta, brings more than 20 years of clinical, academic and research experience in medicine and the sub-specialty of Infectious Diseases, including the approval of several antibiotic medicines and previously served as Vice President of Clinical Development at Iterum from 2016 to 2018. Most recently Dr. Puttagunta served as Chief Medical Officer at BiomX Inc., a public biotechnology company.